Estrogen and Cognition, with a Focus on Alzheimer's Disease

ABSTRACT

Cognitive aging is associated with decreases in memory, attention, and visual/motor performance and skills. Dementia consists of loss of memory and other cognitive abilities, associated with social or occupational impairment. Potential neuroprotective effects of estrogen include lowering β-amyloid, enhancing cholinergic function, promoting synaptic plasticity and nerve process growth, reducing oxidative stress, and enhancing brain glucose transport. Observational and longitudinal studies suggest that hormone therapy may attenuate age-associated cognitive impairment or decrease Alzheimer's disease but this has not been confirmed by randomized clinical trials. A critical window of time may exist around the menopause when hormone therapy may delay or decrease cognitive changes; however, hormone therapy initiated in the late postmenopause does not improve global cognition and may increase dementia risk.

KEYWORDS

Estrogen - cognition - dementia - memory - Alzheimer's disease

REFERENCES

• 1 Sherwin B B. Estrogen and cognitive functioning in women.  Endocr Rev. 2003;  24 133-151
• 2 Grady C L, Craik F IM. Changes in memory processing with age.  Curr Opin Neurobiol. 2000;  10 224-231
• 3 Just M A, Carpenter P A, Keller T A. The capacity theory of comprehension: new frontiers of evidence and arguments.  Psychol Rev. 1996;  103 773-780
• 4 Ashman T A, Mohs R C, Harvey P D. Cognition and aging. In: Hazzard WR, Blass JP, Ettinger WH, et al Principles of Geriatric Medicine and Gerontology, 4th ed. New York; McGraw-Hill 1999: 1219-1228
• 5 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, 4th ed. Washington, DC; American Psychiatric Association 1994
• 6 Petersen R C. Mild cognitive impairment clinical trials.  Nature Reviews. Drug Discovery. 2003;  2 646-653
• 7 Petersen R C, Doody R, Kurz A et al.. Current concepts in mild cognitive impairment.  Arch Neurol. 2001;  58 1985-1992
• 8 Henderson W V. Hormone therapy and Alzheimer's disease: benefit or harm?.  Expert Opin Pharmacother. 2004;  5 389-406
• 9 Shughrue P J, Lane M V, Merchenthaler I. Comparative distribution of estrogen receptor alpha and beta mRMA in the rat central nervous system.  J Comp Neurol. 1997;  388 507-525
• 10 Weiland N G, Orikasa C, Hayashi S, McEwen B S. Distribution and hormone regulation of estrogen receptor immunoreactive cells in the hippocampus of male and female rats.  J Comp Neurol. 1997;  388 603-612
• 11 Shugrue P J, Scrimo P J, Merchenthaler I. Estrogen binding and estrogen receptor characterization in the cholinergic neurons of the rat basal forebrain.  Neuroscience. 2000;  96 41-49
• 12 Shughrue P J, Merchenthaler I. Estrogen is more than just in “sex hormones”; novel sites for estrogen action in the hippocampus and cerebral cortex.  Front Neuroendocrinol. 2000;  21 95-101
• 13 McEwen B S. Estrogen action throughout the brain.  Recent Prog Horm Res. 2002;  57 357-384
• 14 Kugaya A, Epperson C N, Zoghbi S et al.. Increase in prefrontal cortex serotonin receptors following estrogen treatment in postmenopausal women.  Am J Psychiatry. 2003;  160 1522-1524
• 15 Luine V. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats.  Exp Neurol. 1985;  89 484-490
• 16 Birge S J. HRT and cognitive function: what are we to believe?.  Menopause. 2002;  221-223
• 17 Henderson V W. Hormone Therapy and the Brain: A Clinical Perspective on the Role of Estrogen. New York; Parthenon Publishing 2000
• 18 Ohkura T, Teshima Y, Isse K et al.. Estrogen increases cerebral and cerebellar blood flows in post menopausal women.  Menopause. 1995;  2 13-18
• 19 Greene R A. Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease.  Int J Fertil Womens Med. 2000;  45 253-257
• 20 Resnick S M, Maki P M, Golski S, Kraut M A, Zonderman A B. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance.  Horm Behav. 1998;  34 171-182
• 21 Maki P M, Resnick S M. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition.  Neurobiol Aging. 2000;  21 373-383
• 22 Halpen D F. Sex Differences in Cognitive Abilities, 2nd ed. Hillsdale, NJ; Newday Lawrence Erlbaum Assoc 1992
• 23 Cholerton B, Gleason C E, Baker L D, Asthana S. Estrogen and Alzheimer's disease: the story so far.  Drugs Aging. 2002;  19 405-427
• 24 Maki P M, Rich J B, Rosenbaum R S. Implicit memory varies across the menstrual cycle: estrogen effects in young women.  Neuropsychologia. 2002;  40 518-529
• 25 Hampson E, Kimura D. Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills.  Behav Neurosci. 1988;  102 456-459
• 26 Resnick S M, Metter E J, Zonderman A B. Estrogen replacement therapy and longitudinal decline in visual memory: a possible protective effect?.  Neurology. 1997;  49 1491-1497
• 27 Jacobs D M, Tang M -X, Stern Y et al.. Cognitive functioning in nondemented older women who took estrogen after menopause.  Neurology. 1998;  50 368-373
• 28 Steffens D C, Norton M C, Plassman B L et al.. Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women.  J Am Geriatr Soc. 1999;  47 1171-1175
• 29 Matthews K, Cauley J, Yaffe K, Zmuda J M. Estrogen replacement therapy and cognitive decline in older community women.  J Am Geriatr Soc. 1999;  47 518-523
• 30 Zec R F, Trivedi M A. The effects of ERT on neuropsychological function in postmenopausal women with and without dementia: a critical and theoretical review.  Neuropsychology Review. 2002;  12 65-109
• 31 Sherwin B B. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women.  Psychoneuroendocrinology. 1988;  13 345-357
• 32 Phillips S M, Sherwin B B. Effects of estrogen on memory function in surgically menopausal women.  Psychoneuroendocrinology. 1992;  17 485-495
• 33 Sherwin B B, Tulandi I. “Add back” estrogen reverses cognitive deficits induced by a GnRH agonist in women with leiomyomatous uteri.  J Clin Endocrinol Metab. 1996;  81 2545-2549
• 34 Shaywitz S E, Naftolin F, Phil D et al.. Better oral reading and short term memory in midlife, postmenopausal women taking estrogen.  Menopause. 2003;  10 420-426
• 35 Shaywitz S E, Shaywwitz B A, Pugh K R et al.. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks.  JAMA. 1999;  281 1197-1202
• 36 Kukull W A, Ganguli M. Epidemiology of dementia: concepts and overview.  Neurol Clin North Am. 2000;  18 923-949
• 37 Jorm A F, Korten A E, Henderson A S. The prevalence of dementia: a quantitative integration of the literature.  Acta Psychiatr Scand. 1987;  76 465-479
• 38 Gao S, Hendrie H C, Hall K S, Hui S. The relationships between age, sex, and incidence of dementia and Alzheimer disease: a meta-analysis.  Arch Gen Psychiatry. 1998;  55 809-815
• 39 Selkoe D J. Alzheimer's disease: genes, proteins, and therapy.  Physiol Rev. 2001;  81 741-746
• 40 Farrer L A, Cupples L A, Haines J L et al.. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease.  JAMA. 1997;  278 1349-1356
• 41 Petanceska S S, Nagy G, Frail D, Gandy S. Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain.  Neurology. 2000;  54 2212-2217
• 42 Goodman Y, Bruce A J, Cheng B, Mattson M P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons.  J Neurochem. 1996;  66 1836-1844
• 43 Pike C J. Estrogen modulates neuronal Bcl-x_L expression and b-amyloid-induced apoptosis: relevance to Alzheimer's disease.  J Neurochem. 1999;  72 1552-1563
• 44 Foy M R, Henderson V W, Berger T W, Thompson R F. Estrogen and neural plasticity.  Curr Dir Psychol Sci. 2000;  9 148-152
• 45 Shughrue P J, Scrimo P J, Merchenthaler I. Estrogen binding and estrogen receptor characterization (ERalpha and ERbeta) in the cholinergic neurons of the rat basal forebrain.  Neuroscience. 2000;  96 41-49
• 46 Behl C, Skutella T, Lezoualch F et al.. Neuroprotection against oxidative stress by estrogens: structure-activity relationship.  Mol Pharmacol. 1997;  51 535-541
• 47 Simpkins J W, Green P S, Gridley K E, Singh M, de Fiebre N C, Rajakumar G. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease.  Am J Med. 1997;  103 19S-25S
• 48 Seshadri S, Beiser A, Selhub J et al.. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.  N Engl J Med. 2002;  346 476-483
• 49 Whitmer R A, Haan M N, Miller J W, Yaffe K. Hormone replacement therapy and cognitive performance: the role of homocysteine.  J Gerontol A Biol Sci Med Sci. 2003;  58 322-323
• 50 Wassertheil-Smoller S, Hendrix S, Limacher M et al.. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.  JAMA. 2003;  289 2673-2684
• 51 Anderson G L, Limacher M, Assaf A R et al.. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.  JAMA. 2004;  291 1701-1712
• 52 Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women.  JAMA. 1998;  279 688-695
• 53 Hogervorst E, Williams J, Budge M, Riedel W, Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.  Neuroscience. 2000;  101 485-512
• 54 Zandi P P, Carlson M C, Plassman B L et al.. Hormone replacement therapy and incidence of Alzheimer's disease on older women: the Cache County study.  JAMA. 2002;  288 2123-2129
• 55 Paganini-Hill A, Henderson V W. Estrogen replacement therapy and risk of Alzheimer's disease.  Arch Intern Med. 1996;  156 2213-2217
• 56 Tang M-X, Jacobs D, Stern Y et al.. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.  Lancet. 1996;  348 429-432
• 57 Waring S C, Rocca W A, Petersen R C et al.. Postmenopausal estrogen replacement therapy and risk of AD: a population-based study.  Neurology. 1999;  52 965-970
• 58 Matthews K A, Kuller L H, Wing R R, Meilahn E N, Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers?.  Am J Epidemiol. 1996;  143 971-978
• 59 Shumaker S A, Legault C, Rapp S R et al.. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study (WHIMS).  JAMA. 2003;  289 2651-2662
• 60 Rapp S R, Espeland M A, Shumaker S A et al.. The effect of estrogen with progestin treatment on global cognitive function in postmenopausal women: results from the Women's Health Initiative Memory Study.  JAMA. 2003;  289 2663-2672
• 61 Shumaker S A, Legault C, Kuller L et al.. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.  JAMA. 2004;  291 2947-2958
• 62 Espeland M A, Rapp S R, Shumaker S A et al.. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.  JAMA. 2004;  291 2959-2968
• 63 Henderson V W, Benke K S, Green R C, Cupples L A, Farrer L A. for the MIRAGE Study Group. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age.  J Neurol Neurosurg Psychiatry. 2005;  76 103-115
• 64 Resnick S M, Henderson V W. Hormone therapy and risk of Alzheimer disease: a critical time.  JAMA. 2002;  288 2170-2172
• 65 Herrington D M, Espeland M A, Crouse J R et al.. Estrogen replacement and brachial artery flow-mediated vasodilation in older women.  Arterioscler Thromb Vasc Biol. 2001;  21 1955-1961
• 66 Hodis H N, Mack W J, Lobo R A et al.. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.  Ann Intern Med. 2001;  135 939-953
• 67 Hodis H N, Mack W J, Azen S P et al.. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.  N Engl J Med. 2003;  349 535-545
• 68 Savonenko A V, Markowska A L. The cognitive effects of ovariectomy and estrogen replacement are modulated by aging.  Neuroscience. 2003;  119 821-830
• 69 Mulnard R A, Cotman C W, Kawas C et al.. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial.  JAMA. 2000;  283 1007-1015
• 70 Henderson V W, Paganini-Hill A, Miller B L et al.. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial.  Neurology. 2000;  54 295-301
• 71 Wang P N, Liao S Q, Liu R S et al.. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.  Neurology. 2000;  54 2061-2066
• 72 Asthana S, Baker L D, Craft S et al.. High-dose estradiol improves cognition for women with AD: results of a randomized study.  Neurology. 2001;  57 605-612
• 73 Schneider L S, Farlow M R, Henderson V W, Pogoda J M. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease.  Neurology. 1996;  46 1580-1584
• 74 Rigaud A S, Andre G, Vellas B, Touchon J, Pere J J. No additional benefit of HRT on response to rivastigmine in menopausal women with AD.  Neurology. 2003;  60 148-149